Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis

BACKGROUND: Osteoarthritis (OA) involves cartilage changes as well as modifications of subchondral bone and synovial tissues. Strontium ranelate (SR), an anti-osteoporosis compound, which is currently in phase III clinical trial for treatment of OA. Evidences suggest that SR preferably deposited in...

詳細記述

保存先:
書誌詳細
出版年:BMC Musculoskelet Disord
主要な著者: Chu, Jian-Guo, Dai, Mu-Wei, Wang, Yu, Tian, Fa-Ming, Song, Hui-Ping, Xiao, Ya-Ping, Shao, Li-Tao, Zhang, Ying-Ze, Zhang, Liu
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5303224/
https://ncbi.nlm.nih.gov/pubmed/28187731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-017-1399-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料